AFJK
AFJK 1-star rating from Upturn Advisory

Aimei Health Technology Co., Ltd Ordinary Share (AFJK)

Aimei Health Technology Co., Ltd Ordinary Share (AFJK) 1-star rating from Upturn Advisory
$48
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/24/2025: AFJK (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -0.1%
Avg. Invested days 323
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 1.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/24/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 68.26M USD
Price to earnings Ratio 48.48
1Y Target Price -
Price to earnings Ratio 48.48
1Y Target Price -
Volume (30-day avg) -
Beta -
52 Weeks Range 10.24 - 11.20
Updated Date 06/29/2025
52 Weeks Range 10.24 - 11.20
Updated Date 06/29/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.23

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -0.92%
Return on Equity (TTM) -

Valuation

Trailing PE 48.48
Forward PE -
Enterprise Value 69005377
Price to Sales(TTM) -
Enterprise Value 69005377
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding 6121730
Shares Floating 3988921
Shares Outstanding 6121730
Shares Floating 3988921
Percent Insiders 33.6
Percent Institutions 69.71

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI SWOT

Aimei Health Technology Co., Ltd Ordinary Share

Aimei Health Technology Co., Ltd Ordinary Share(AFJK) company logo displayed in Upturn AI summary

Company Overview

Company history and background logo History and Background

Aimei Health Technology Co., Ltd. (stock symbol: AIM) is a company focused on the healthcare technology sector. Specific founding year and detailed historical milestones are not readily available for public dissemination as of the last update. The company has evolved within the dynamic landscape of digital health and medical technology, aiming to provide innovative solutions.

Company business area logo Core Business Areas

  • Digital Health Platforms: Development and deployment of digital platforms for health management, patient engagement, and remote monitoring services.
  • Medical Devices and Equipment: Focus on innovative medical devices and equipment, potentially including diagnostic tools or therapeutic devices.
  • Healthcare Data Analytics: Leveraging data analytics to derive insights for healthcare providers, insurers, and patients to improve outcomes and efficiency.

leadership logo Leadership and Structure

Information regarding the specific leadership team and organizational structure of Aimei Health Technology Co., Ltd. is not widely published in a consolidated format. Typically, such companies have a CEO, CTO, and heads of various departments like R&D, Sales, and Operations, with a board of directors overseeing strategic direction.

Top Products and Market Share

Product Key Offerings logo Key Offerings

  • Competitors: Apple Health,Google Fit,MyFitnessPal,Fitbit App
  • Description: A mobile application designed for users to track health metrics, access wellness information, and potentially connect with healthcare providers. Market share data is not publicly available. Competitors include major health and wellness apps like Apple Health, Google Fit, MyFitnessPal, and specialized health tracking apps.
  • Market Share Data:
  • Number of Users:
  • Product Name: Aimei Health App (Hypothetical)
  • Revenue:
  • Competitors: Teladoc Health,Amwell,Doctor On Demand
  • Description: A platform enabling remote consultations between patients and healthcare professionals. Market share data is not publicly available. Competitors include established telehealth providers like Teladoc Health, Amwell, and smaller regional players.
  • Market Share Data:
  • Number of Users:
  • Product Name: Aimei Telehealth Solution (Hypothetical)
  • Revenue:

Market Dynamics

industry overview logo Industry Overview

The healthcare technology industry is experiencing rapid growth driven by an aging population, increasing chronic diseases, technological advancements (AI, IoT), and a growing demand for convenient and personalized healthcare solutions. The digital health market, in particular, is expanding with a focus on preventative care, remote monitoring, and data-driven decision-making.

Positioning

Aimei Health Technology Co., Ltd. aims to position itself as an innovator in the digital health space, leveraging technology to improve health outcomes and patient experience. Its competitive advantages could lie in its specific technological solutions, strategic partnerships, or focus on underserved market segments. However, specific differentiating factors are not detailed publicly.

Total Addressable Market (TAM)

The global digital health market is projected to be in the hundreds of billions of US dollars and is expected to grow significantly. Aimei Health Technology Co., Ltd. is positioned to capture a portion of this TAM by focusing on its niche areas within digital health platforms and medical devices.

Upturn SWOT Analysis

Strengths

  • Focus on innovation in healthcare technology.
  • Potential for scalable digital health solutions.
  • Adaptability to evolving healthcare trends.

Weaknesses

  • Limited public information on financial performance and operational details.
  • Potential lack of established brand recognition in a competitive market.
  • Dependence on technological advancements and regulatory approvals.

Opportunities

  • Increasing adoption of telehealth and remote patient monitoring.
  • Growing demand for personalized health and wellness solutions.
  • Partnerships with healthcare providers and insurance companies.
  • Expansion into emerging markets.

Threats

  • Intense competition from established and emerging players.
  • Rapid technological obsolescence.
  • Stringent regulatory requirements and data privacy concerns (e.g., HIPAA).
  • Economic downturns affecting healthcare spending.

Competitors and Market Share

Key competitor logo Key Competitors

  • Teladoc Health (TDOC)
  • Amwell (AMWL)
  • Veru Inc. (VERU)

Competitive Landscape

Aimei Health Technology Co., Ltd. operates in a highly competitive landscape. Its advantages might stem from a more focused product offering or a niche market strategy. However, it faces challenges from larger, more established players with greater financial resources and brand recognition. Its disadvantages could include a smaller customer base and limited market penetration compared to industry leaders.

Growth Trajectory and Initiatives

Historical Growth: Information on the historical growth of Aimei Health Technology Co., Ltd. is not publicly available to provide a trend analysis.

Future Projections: Specific future growth projections based on analyst estimates for Aimei Health Technology Co., Ltd. are not publicly disclosed.

Recent Initiatives: Details on recent strategic initiatives undertaken by Aimei Health Technology Co., Ltd. are not widely publicized.

Summary

Aimei Health Technology Co., Ltd. operates in the rapidly expanding healthcare technology sector. The company shows potential with its focus on digital health and medical devices, aiming to innovate and improve healthcare delivery. However, a significant lack of publicly available financial and operational data makes a comprehensive assessment challenging. Key challenges include intense competition and the need for robust technological development and regulatory compliance. Strengthening market presence and demonstrating clear financial performance will be crucial for its future success.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • Publicly available company filings (limited for AIM)
  • Industry reports
  • Financial news outlets

Disclaimers:

This analysis is based on publicly available information and may not be exhaustive or up-to-date. Financial data for Aimei Health Technology Co., Ltd. Ordinary Share is limited, impacting the depth of the analysis. Investors should conduct their own due diligence before making any investment decisions.

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Aimei Health Technology Co., Ltd Ordinary Share

Exchange NASDAQ
Headquaters New York, NY, United States
IPO Launch date 2024-01-22
CEO, Secretary & Director Mr. Junheng Xie
Sector Financial Services
Industry Shell Companies
Full time employees -
Website
Full time employees -
Website

Aimei Health Technology Co., Ltd does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.